XASE · MTNB
-9.23% · -$0.0268 · Vol 748.9K
After hours · updated 18:07:22 ET
Matinas BioPharma Holdings, Inc.
PHARMACEUTICAL PREPARATIONS
$0.2637
Veridion Score
BETAHIGH CONF · 6/6 factorsWed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET · MTNB
MethodologyMTNB
Matinas BioPharma Holdings, Inc.
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
58/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is MTNB moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Matinas BioPharma Holdings, Inc.
PHARMACEUTICAL PREPARATIONSListed since
2014
Employees
2
Country
US
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$0.2818
Day high
$0.2982
Day low
$0.2615
Previous close
$0.2905
52W high
$2.36
-88.83% from high
52W low
$0.2414
1% of range
Market cap
$1.9M
EPS
$-2.0600
Beta
0.44
Shares out
6.4M
Volume
748.9K
0.07× rel vol
Avg volume
10.6M
VWAP
$0.2760
Price history computed in-house
1W
-11.48%
1M
-58.01%
3M
-59.12%
1Y
-71.65%
YTD
-55.00%
SMA 50 $0.5693 · below
SMA 200 $0.7067 · below
52W position 1%
MTNB overview
Veridion Score
58
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in MTNB
No receipt-qualified Congressional disclosure is present for MTNB in the cached public ledger.
Federal contracts
MTNB contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MTNB in this window.
Lobbying spend
MTNB lobbying filings, year to date.
Registered lobbying filings matched to Matinas BioPharma Holdings, Inc..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MTNB in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for MTNB.
Options
Sovereign unlock shows live options positioning for MTNB.